Daily Hampshire Gazette - Established 1786
Hi 27° | Lo 17°

Donald Mathison: FDA’s overruling of advisory panel questioned

To the editor:

The drug company that produces Zohydro filed a lawsuit following the governor’s ban on its use in Massachusetts, claiming that because it had been approved by the FDA, Massachusetts was overstepping its authority. What seems to be lost in all this hoopla is the fact that the FDA’s advisory committee opposed its release by a vote of 11-2. How much confidence can you have in the FDA when the drug companies have considerably more weight than the advisory committee?

Donald Mathison


Legacy Comments0
There are no comments yet. Be the first!
Post a Comment

You must be registered to comment on stories. Click here to register.